Brokerages predict that UnitedHealth Group Inc (NYSE:UNH) will report $57.62 billion in sales for the current fiscal quarter, according to Zacks. Seven analysts have issued estimates for UnitedHealth Group’s earnings. The highest sales estimate is $58.42 billion and the lowest is $56.87 billion. UnitedHealth Group posted sales of $52.06 billion in the same quarter last year, which would indicate a positive year over year growth rate of 10.7%. The firm is expected to issue its next earnings report on Tuesday, January 15th.
On average, analysts expect that UnitedHealth Group will report full-year sales of $225.03 billion for the current financial year, with estimates ranging from $224.02 billion to $226.25 billion. For the next year, analysts expect that the business will post sales of $243.70 billion, with estimates ranging from $242.06 billion to $246.17 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research analysts that follow UnitedHealth Group.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.30 by $0.11. UnitedHealth Group had a return on equity of 22.79% and a net margin of 5.55%. The business had revenue of $56.56 billion during the quarter, compared to analysts’ expectations of $56.34 billion. During the same period in the previous year, the firm posted $2.66 earnings per share. The company’s revenue was up 12.4% on a year-over-year basis.
In related news, CEO Steven H. Nelson sold 8,142 shares of the company’s stock in a transaction dated Thursday, September 13th. The stock was sold at an average price of $265.00, for a total transaction of $2,157,630.00. Following the transaction, the chief executive officer now directly owns 22,496 shares of the company’s stock, valued at approximately $5,961,440. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Richard T. Burke sold 15,000 shares of the company’s stock in a transaction dated Wednesday, August 1st. The shares were sold at an average price of $254.79, for a total value of $3,821,850.00. The disclosure for this sale can be found here. Insiders sold a total of 94,568 shares of company stock valued at $24,950,027 over the last quarter. Company insiders own 0.87% of the company’s stock.
Several hedge funds have recently made changes to their positions in UNH. FMR LLC lifted its position in shares of UnitedHealth Group by 5.1% in the second quarter. FMR LLC now owns 61,622,355 shares of the healthcare conglomerate’s stock valued at $15,118,428,000 after acquiring an additional 2,981,233 shares in the last quarter. Wells Fargo & Company MN lifted its position in UnitedHealth Group by 0.5% during the second quarter. Wells Fargo & Company MN now owns 7,692,899 shares of the healthcare conglomerate’s stock worth $1,887,377,000 after buying an additional 39,480 shares in the last quarter. Jennison Associates LLC increased its stake in UnitedHealth Group by 12.0% during the second quarter. Jennison Associates LLC now owns 6,616,652 shares of the healthcare conglomerate’s stock worth $1,623,329,000 after acquiring an additional 710,745 shares during the last quarter. Summit Trail Advisors LLC increased its stake in UnitedHealth Group by 19,286.4% during the first quarter. Summit Trail Advisors LLC now owns 6,228,065 shares of the healthcare conglomerate’s stock worth $6,228,000 after acquiring an additional 6,195,939 shares during the last quarter. Finally, Morgan Stanley increased its stake in UnitedHealth Group by 5.2% during the second quarter. Morgan Stanley now owns 5,498,557 shares of the healthcare conglomerate’s stock worth $1,349,017,000 after acquiring an additional 269,652 shares during the last quarter. 85.35% of the stock is currently owned by institutional investors and hedge funds.
NYSE:UNH opened at $266.81 on Friday. The firm has a market capitalization of $256.06 billion, a P/E ratio of 26.50, a P/E/G ratio of 1.58 and a beta of 0.73. The company has a quick ratio of 0.75, a current ratio of 0.75 and a debt-to-equity ratio of 0.63. UnitedHealth Group has a 12-month low of $202.70 and a 12-month high of $272.81.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: What is a stock split?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.